Loading...

Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV – focus on pegylated interferon-alpha

In immuno-competent individuals, the natural course of chronic hepatitis C virus (HCV) infection is highly variable and 5%–30% of patients develop cirrhosis over 20 years. Co-infection with HCV and human immunodeficiency virus (HIV) is an important prognostic factor and associated with more frequent...

Full description

Saved in:
Bibliographic Details
Main Authors: Zoller, Heinz, Vogel, Wolfgang
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2006
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2676642/
https://ncbi.nlm.nih.gov/pubmed/17722274
Tags: Add Tag
No Tags, Be the first to tag this record!